EXAMPLE 3- Preparation of 1-(2-(4-benzoyl-piperazinyl)ethyl)-1,4-dihydro-7-methoxy-4,4-dimethylchromeno[4,3-c]pyrazole.
The desired compound was prepared according to the procedure described for Example 1 using 1-(2-bromoethyl)-7-methoxy-4,4-dimethyl-1,4-dihydrochromeno[4,3-c]pyrazole (20 mg, 0.06 mmol) and benzoylpiperazine (11 mg, 0.06 mmol). Yellow amorphous solid (8 mg, 30%);